CASI 241220 5.00P (CASI241220P5000) Stock Options, News & Quotes

US OptionsDetailed Quotes

CASI241220P5000

Watchlist

0.00
0.000.00%

15min DelayClose Nov 27 09:30 ET

0.00High0.00Low

Intraday

5D
Daily

No Data

News

Earnings Flash (CASI) CASI PHARMACEUTICALS Reports Q3 Revenue $7.8M
MT NewswiresNov 15 08:25 ET
CASI Pharmaceuticals Reports Q3 Results
Seeking AlphaNov 15 08:06 ET
Earnings Scheduled For November 14, 2024
BenzingaNov 14 03:32 ET
Here's the Major Earnings Before the Open Tomorrow
Seeking AlphaNov 13 18:00 ET
Earnings Preview: CASI to Report Financial Results Pre-market on November 14
Moomoo NewsNov 8 20:00 ET
Casi Pharmaceuticals Says China Cleared Phase 1/2 Trial in Immune Thrombocytopenia
MT NewswiresOct 24 11:16 ET

Comments

Jaguar8

Oct 24 07:05

NEWS

$CASI Pharmaceuticals (CASI.US)$
CASI Pharmaceuticals Receives CTA Approval From China's NMPA for CID-103 in Immune Thrombocytopenia
CASI Pharmaceuticals (NASDAQ:CASI) has received Clinical Trial Application (CTA) approval from China's NMPA to conduct a phase 1/2 study of CID-103 in adult patients with chronic Immune Thrombocytopenia (ITP). The China study is part of a global study previously approved by the US FDA in May 2024. CID-103 is a fully human IgG1 anti-CD38 monoclonal antibody that...